Literature DB >> 22348538

Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cells.

Bärbel Heydenreich1, Iris Bellinghausen, Steffen Lorenz, Helene Henmar, Dennis Strand, Peter A Würtzen, Joachim Saloga.   

Abstract

Although allergen-specific immunotherapy is a clinically effective therapy for IgE-mediated allergic diseases, the risk of IgE-mediated adverse effects still exists. For this reason, chemically modified allergoids have been introduced, which may destroy IgE-binding sites while T-cell activation should be retained. The aim of the study was to analyse the differences between intact allergens and differently modified/aggregated allergoids concerning their internalization as well as T-cell and basophil activation. For this purpose human monocyte-derived immature dendritic cells (DC) were incubated with Phleum pratense or Betula verrucosa pollen extract or with the corresponding allergoids, modified with formaldehyde or glutaraldehyde. After an additional maturation process, the antigen-loaded mature DC were co-cultured with autologous CD4(+) T cells. Allergenicity was tested by leukotriene release from basophils. In addition, the uptake of intact allergens and allergoids by immature DC was analysed. The proliferation of, as well as the interleukin-4 (IL-4), IL-10, IL-13 and interferon-γ production by, CD4(+) T cells which had been stimulated with glutaraldehyde allergoid-treated DC was reduced compared with CD4(+) T cells stimulated with intact allergen-treated or formaldehyde allergoid-treated DC. In line with this, glutaraldehyde-modified allergoids were more aggregated and were internalized more slowly. Furthermore, only the allergoids modified with glutaraldehyde induced a decreased leukotriene release by activated basophils. These findings suggest that IgE-reactive epitopes were destroyed more efficiently by modification with glutaraldehyde than with formaldehyde under the conditions chosen for these investigations. Glutaraldehyde-modified allergoids also displayed lower T-cell stimulatory capacity, which is mainly the result of greater modification/aggregation and diminished uptake by DC.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348538      PMCID: PMC3403258          DOI: 10.1111/j.1365-2567.2012.03571.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

Review 1.  The dendritic cell in allergic airway diseases: a new player to the game.

Authors:  B N Lambrecht
Journal:  Clin Exp Allergy       Date:  2001-02       Impact factor: 5.018

2.  Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes.

Authors:  N Noirey; N Rougier; C André; D Schmitt; C Vincent
Journal:  J Allergy Clin Immunol       Date:  2000-06       Impact factor: 10.793

3.  Reactivity of T cells with grass pollen allergen extract and allergoid.

Authors:  H Kahler; H Stüwe; O Cromwell; H Fiebig
Journal:  Int Arch Allergy Immunol       Date:  1999-10       Impact factor: 2.749

4.  IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.

Authors:  Marek Jutel; Mübeccel Akdis; Ferah Budak; Carmen Aebischer-Casaulta; Maria Wrzyszcz; Kurt Blaser; Cezmi A Akdis
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

Review 5.  IgE regulation and roles in asthma pathogenesis.

Authors:  H C Oettgen; R S Geha
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

6.  Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial.

Authors:  C Caffarelli; L G Sensi; F Marcucci; G Cavagni
Journal:  Allergy       Date:  2000-12       Impact factor: 13.146

7.  T cell reactivity with allergoids: influence of the type of APC.

Authors:  H Kahlert; E Grage-Griebenow; H T Stüwe; O Cromwell; H Fiebig
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

8.  Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.

Authors:  Herbert Riechelmann; Joachim Schmutzhard; Jan F van der Werf; Andreas Distler; Huub A J Kleinjans
Journal:  Am J Rhinol Allergy       Date:  2010 Sep-Oct       Impact factor: 2.467

9.  Analysis of the CD4+ T cell responses to house dust mite allergoid.

Authors:  P Kalinski; M C Lebre; D Kramer; E C De Jong; J W P M Van Schijndel; M L Kapsenberg
Journal:  Allergy       Date:  2003-07       Impact factor: 13.146

10.  Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts.

Authors:  I Ibarrola; M L Sanz; P M Gamboa; A Mir; D Benahmed; A Ferrer; M C Arilla; A Martínez; J A Asturias
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

View more
  5 in total

1.  Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro.

Authors:  B Heydenreich; I Bellinghausen; L Lund; H Henmar; G Lund; P Adler Würtzen; J Saloga
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

2.  Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants.

Authors:  Kathrin Reinmuth-Selzle; Christopher J Kampf; Kurt Lucas; Naama Lang-Yona; Janine Fröhlich-Nowoisky; Manabu Shiraiwa; Pascale S J Lakey; Senchao Lai; Fobang Liu; Anna T Kunert; Kira Ziegler; Fangxia Shen; Rossella Sgarbanti; Bettina Weber; Iris Bellinghausen; Joachim Saloga; Michael G Weller; Albert Duschl; Detlef Schuppan; Ulrich Pöschl
Journal:  Environ Sci Technol       Date:  2017-04-06       Impact factor: 9.028

3.  Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities.

Authors:  S Starchenka; A J Bell; J Mwange; M A Skinner; M D Heath
Journal:  World Allergy Organ J       Date:  2017-04-24       Impact factor: 4.084

Review 4.  Novel strategies in immunotherapy for allergic diseases.

Authors:  Mohana Rajakulendran; Elizabeth Huiwen Tham; Jian Yi Soh; H P Van Bever
Journal:  Asia Pac Allergy       Date:  2018-04-09

5.  Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines.

Authors:  Ana I Manzano; F Javier Cañada; Bárbara Cases; Sofia Sirvent; Irene Soria; Oscar Palomares; Enrique Fernández-Caldas; Miguel Casanovas; Jesús Jiménez-Barbero; José L Subiza
Journal:  Glycoconj J       Date:  2015-11-25       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.